AI Verdict
REGN has stronger fundamentals based on our AI analysis.
GILD vs REGN Fundamental Comparison
| Metric | GILD | REGN |
|---|---|---|
| Revenue | $7.0B | $3.6B |
| Net Income | $2.0B | $727.2M |
| Net Margin | 29.0% | 20.2% |
| ROE | 8.6% | 2.3% |
| ROA | 3.6% | 1.8% |
| Current Ratio | 1.97x | 3.57x |
| Debt/Equity | 0.94x | 0.06x |
| EPS | $1.61 | $6.75 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GILD vs REGN: Frequently Asked Questions
Is GILD or REGN the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), REGN has stronger fundamentals. GILD is graded A (78% confidence) while REGN is graded A (80% confidence). This is not investment advice.
How does GILD compare to REGN fundamentally?
GILEAD SCIENCES, INC. has ROE of 8.6% vs REGENERON PHARMACEUTICALS, INC.'s 2.3%. Net margins are 29.0% vs 20.2% respectively.
Which stock pays higher dividends, GILD or REGN?
GILD has a dividend yield of N/A or no dividend while REGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GILD or REGN for long term?
For long-term investing, consider that GILD has a A grade with 78% confidence, while REGN has a A grade with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GILD vs REGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GILD vs REGN, the AI consensus favors REGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.